Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Calls For Pre-Market CV Safety Trials For Some Constipation Drugs

Sep 23 2011

• By Emily Hayes

Related Content

Orexigen Resurrects Contrave With New Trial Agreement With FDA

Sep 20 2011

Door Open For Zelnorm Return Despite Marketing “Suspension,” Novartis Says

Apr 02 2007

J&J Propulsid Compassionate IND Program Expands To Allow Emergency Use

Dec 04 2000

With Diminishing Cash, Aryx Seeks Pharma Partners For Mid-Stage Assets

May 13 2010

GI Drugs Cmte. To Weigh Retreatment Study Design For Salix's Xifaxan In Irritable Bowel

Sep 23 2011

Market Snapshot: Taking Constipation Seriously – Linaclotide Success Raises Hopes For Market Resurgence

Jul 04 2011

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window